146 related articles for article (PubMed ID: 2426299)
1. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
2. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
[TBL] [Abstract][Full Text] [Related]
3. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins.
Lindefors N; Brodin E; Theodorsson-Norheim E; Ungerstedt U
Regul Pept; 1985 Mar; 10(2-3):217-30. PubMed ID: 2581287
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
6. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
Vinik AI; Gonin J; England BG; Jackson T; McLeod MK; Cho K
J Clin Endocrinol Metab; 1990 Jun; 70(6):1702-9. PubMed ID: 1693375
[TBL] [Abstract][Full Text] [Related]
7. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.
Norheim I; Oberg K; Theodorsson-Norheim E; Lindgren PG; Lundqvist G; Magnusson A; Wide L; Wilander E
Ann Surg; 1987 Aug; 206(2):115-25. PubMed ID: 2440390
[TBL] [Abstract][Full Text] [Related]
8. Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K; Lundqvist G; Rosell S
Regul Pept; 1984 Nov; 9(4):245-57. PubMed ID: 6084259
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
Lundin L; Norheim I; Landelius J; Oberg K; Theodorsson-Norheim E
Circulation; 1988 Feb; 77(2):264-9. PubMed ID: 2448062
[TBL] [Abstract][Full Text] [Related]
11. Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements.
Oberg K; Theodorsson-Norheim E; Norheim I
Scand J Gastroenterol; 1987 Nov; 22(9):1041-8. PubMed ID: 2447632
[TBL] [Abstract][Full Text] [Related]
12. Tachykinins in endocrine tumors and the carcinoid syndrome.
Cunningham JL; Janson ET; Agarwal S; Grimelius L; Stridsberg M
Eur J Endocrinol; 2008 Sep; 159(3):275-82. PubMed ID: 18524798
[TBL] [Abstract][Full Text] [Related]
13. Flushing in the carcinoid syndrome and plasma kallikrein.
Lucas KJ; Feldman JM
Cancer; 1986 Nov; 58(10):2290-3. PubMed ID: 2428458
[TBL] [Abstract][Full Text] [Related]
14. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing features of idiopathic flushing and carcinoid syndrome.
Aldrich LB; Moattari AR; Vinik AI
Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
[TBL] [Abstract][Full Text] [Related]
16. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors.
Richter G; Stöckmann F; Conlon JM; Creutzfeldt W
Gastroenterology; 1986 Sep; 91(3):612-8. PubMed ID: 2426155
[TBL] [Abstract][Full Text] [Related]
17. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.
Conlon JM; Deacon CF; Richter G; Stöckmann F; Creutzfeldt W
Scand J Gastroenterol; 1987 Jan; 22(1):97-105. PubMed ID: 2882598
[TBL] [Abstract][Full Text] [Related]
18. Biochemical diagnosis of neuroendocrine GEP tumor.
Oberg K
Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
[TBL] [Abstract][Full Text] [Related]
19. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.
Ahlman H; Dahlström A; Grönstad K; Tisell LE; Oberg K; Zinner MJ; Jaffe BM
Ann Surg; 1985 Jan; 201(1):81-6. PubMed ID: 2578277
[TBL] [Abstract][Full Text] [Related]
20. Circulation of a fragment of haemoglobin alpha-chain during a pentagastrin-induced flush in patients with metastatic carcinoid tumours.
Balks HJ; Thim L; Conlon JM
Clin Endocrinol (Oxf); 1988 Mar; 28(3):261-9. PubMed ID: 3168309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]